{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:25:04Z","timestamp":1789388704012,"version":"build-2803163510"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Aging"],"DOI":"10.1038\/s41514-025-00212-5","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:18:45Z","timestamp":1751354325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Potential of biomarkers of ageing in predicting severity of influenza virus infection and vaccination efficacy"],"prefix":"10.1038","volume":"11","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liaqat","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"212_CR1","doi-asserted-by":"crossref","unstructured":"Morris, D. H. et al. Asynchrony between virus diversity and antibody selection limits influenza virus evolution. Elife, 9 (2020).","DOI":"10.7554\/eLife.62105"},{"key":"212_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nrmicro.2017.146","volume":"16","author":"VN Petrova","year":"2018","unstructured":"Petrova, V. N. & Russell, C. A. The evolution of seasonal influenza viruses. Nat. Rev. Microbiol 16, 60 (2018).","journal-title":"Nat. Rev. Microbiol"},{"key":"212_CR3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.bios.2017.08.048","volume":"100","author":"RQ Zhang","year":"2018","unstructured":"Zhang, R. Q. et al. Rapid detection and subtyping of multiple influenza viruses on a microfluidic chip integrated with controllable micro-magnetic field. Biosens. Bioelectron. 100, 348\u2013354 (2018).","journal-title":"Biosens. Bioelectron."},{"key":"212_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41533-021-00251-x","volume":"31","author":"X Li","year":"2021","unstructured":"Li, X. et al. Influenza colloidal gold method and blood routine tests combination for rapid diagnosis of influenza: a decision tree-based analysis. NPJ Prim. Care Respir. Med 31, 39 (2021).","journal-title":"NPJ Prim. Care Respir. Med"},{"key":"212_CR5","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s10096-021-04193-7","volume":"40","author":"N Kaku","year":"2021","unstructured":"Kaku, N. et al. Evaluation of a novel rapid TRC assay for the detection of influenza using nasopharyngeal swabs and gargle samples. Eur. J. Clin. Microbiol Infect. Dis. 40, 1743\u20131748 (2021).","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"key":"212_CR6","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Improved Influenza Diagnostics through Thermal Contrast Amplification. Diagnostics, 11 (2021).","DOI":"10.3390\/diagnostics11030462"},{"key":"212_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/v8040096","volume":"8","author":"SV Vemula","year":"2016","unstructured":"Vemula, S. V. et al. Current Approaches for Diagnosis of Influenza Virus Infections in Humans. Viruses 8, 96 (2016).","journal-title":"Viruses"},{"key":"212_CR8","doi-asserted-by":"publisher","first-page":"e201323","DOI":"10.1001\/jamanetworkopen.2020.1323","volume":"3","author":"EJ Chow","year":"2020","unstructured":"Chow, E. J. et al. Respiratory and Nonrespiratory Diagnoses Associated With Influenza in Hospitalized Adults. JAMA Netw. Open 3, e201323 (2020).","journal-title":"JAMA Netw. Open"},{"key":"212_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-4939-8678-1_2","volume":"1836","author":"Y Ito","year":"2018","unstructured":"Ito, Y. Clinical Diagnosis of Influenza. Methods Mol. Biol. 1836, 23\u201331 (2018).","journal-title":"Methods Mol. Biol."},{"key":"212_CR10","doi-asserted-by":"crossref","unstructured":"Kim, S. H., et al., Differences in Clinical Characteristics and Chest Images between Coronavirus Disease 2019 and Influenza-Associated Pneumonia. Diagnostics, 11 (2021).","DOI":"10.3390\/diagnostics11020261"},{"key":"212_CR11","first-page":"751","volume":"100","author":"DY Gaitonde","year":"2019","unstructured":"Gaitonde, D. Y., Moore, F. C. & Morgan, M. K. Influenza: Diagnosis and Treatment. Am. Fam. Physician 100, 751\u2013758 (2019).","journal-title":"Am. Fam. Physician"},{"key":"212_CR12","doi-asserted-by":"crossref","unstructured":"Group, B.D.W. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharm. Ther. 69, 89\u201395 (2001).","DOI":"10.1067\/mcp.2001.113989"},{"key":"212_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"Califf, R. M. Biomarker definitions and their applications. Exp. Biol. Med. 243, 213\u2013221 (2018).","journal-title":"Exp. Biol. Med."},{"key":"212_CR14","doi-asserted-by":"publisher","first-page":"7047405","DOI":"10.1155\/2017\/7047405","volume":"2017","author":"S Morzunov","year":"2017","unstructured":"Morzunov, S., Deyde, V. & Abrahamyan, L. New Biomarkers of Innate and Adaptive Immunity in Infectious Diseases. J. Immunol. Res 2017, 7047405 (2017).","journal-title":"J. Immunol. Res"},{"key":"212_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1615\/CritRevImmunol.v30.i2.70","volume":"30","author":"LR Goulart","year":"2010","unstructured":"Goulart, L. R. et al. Biomarkers for serum diagnosis of infectious diseases and their potential application in novel sensor platforms. Crit. Rev. Immunol. 30, 201\u2013222 (2010).","journal-title":"Crit. Rev. Immunol."},{"key":"212_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/MOP.0000000000000868","volume":"32","author":"E Nanishi","year":"2020","unstructured":"Nanishi, E., Dowling, D. J. & Levy, O. Toward precision adjuvants: optimizing science and safety. Curr. Opin. Pediatr. 32, 125\u2013138 (2020).","journal-title":"Curr. Opin. Pediatr."},{"key":"212_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ccc.2019.08.014","volume":"36","author":"JL Vincent","year":"2020","unstructured":"Vincent, J. L., Bogossian, E. & Menozzi, M. The Future of Biomarkers. Crit. Care Clin. 36, 177\u2013187 (2020).","journal-title":"Crit. Care Clin."},{"key":"212_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.maturitas.2015.05.004","volume":"82","author":"A Pera","year":"2015","unstructured":"Pera, A. et al. Immunosenescence: Implications for response to infection and vaccination in older people. Maturitas 82, 50\u201355 (2015).","journal-title":"Maturitas"},{"key":"212_CR19","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.4110\/in.2019.19.e37","volume":"19","author":"SJ Oh","year":"2019","unstructured":"Oh, S. J., Lee, J. K. & Shin, O. S. Aging and the Immune System: the Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity. Immune Netw. 19, e37 (2019).","journal-title":"Immune Netw."},{"key":"212_CR20","doi-asserted-by":"publisher","first-page":"020421","DOI":"10.7189\/jogh.09.020421","volume":"9","author":"J Paget","year":"2019","unstructured":"Paget, J. et al. Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project. J. Glob. Health 9, 020421 (2019).","journal-title":"J. Glob. Health"},{"key":"212_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"C Franceschi","year":"2000","unstructured":"Franceschi, C. et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y Acad. Sci. 908, 244\u2013254 (2000).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"212_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11357-012-9381-2","volume":"35","author":"R Macaulay","year":"2013","unstructured":"Macaulay, R., Akbar, A. N. & Henson, S. M. The role of the T cell in age-related inflammation. Age 35, 563\u2013572 (2013).","journal-title":"Age"},{"key":"212_CR23","doi-asserted-by":"publisher","first-page":"C972","DOI":"10.1152\/ajpcell.00402.2014","volume":"308","author":"H Toba","year":"2015","unstructured":"Toba, H. et al. Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarization. Am. J. Physiol. Cell Physiol. 308, C972\u2013C982 (2015).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"212_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep25051","volume":"6","author":"JS Lefebvre","year":"2016","unstructured":"Lefebvre, J. S. et al. Age-related impairment of humoral response to influenza is associated with changes in antigen specific T follicular helper cell responses. Sci. Rep. 6, 25051 (2016).","journal-title":"Sci. Rep."},{"key":"212_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/MAJ.0b013e318256c6aa","volume":"344","author":"M Ruiz","year":"2012","unstructured":"Ruiz, M., Cefalu, C. & Reske, T. Frailty syndrome in geriatric medicine. Am. J. Med Sci. 344, 395\u2013398 (2012).","journal-title":"Am. J. Med Sci."},{"key":"212_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0420-6","volume":"13","author":"JD Walston","year":"2015","unstructured":"Walston, J. D. & Bandeen-Roche, K. Frailty: a tale of two concepts. BMC Med 13, 185 (2015).","journal-title":"BMC Med"},{"key":"212_CR27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4081\/monaldi.2015.727","volume":"84","author":"R Rozzini","year":"2016","unstructured":"Rozzini, R. Aging clinical problems: a difficult balance between age and frailty. Monaldi Arch. Chest Dis. 84, 727 (2016).","journal-title":"Monaldi Arch. Chest Dis."},{"key":"212_CR28","doi-asserted-by":"publisher","first-page":"101351","DOI":"10.1016\/j.arr.2021.101351","volume":"69","author":"DL Vetrano","year":"2021","unstructured":"Vetrano, D. L. et al. Fostering healthy aging: The interdependency of infections, immunity and frailty. Ageing Res. Rev. 69, 101351 (2021).","journal-title":"Ageing Res. Rev."},{"key":"212_CR29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/infdis\/jiaa092","volume":"222","author":"C Lees","year":"2020","unstructured":"Lees, C. et al. Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults. J. Infect. Dis. 222, 428\u2013437 (2020).","journal-title":"J. Infect. Dis."},{"key":"212_CR30","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/ageing\/afl041","volume":"35","author":"DB Rolfson","year":"2006","unstructured":"Rolfson, D. B. et al. Validity and reliability of the Edmonton Frail Scale. Age Ageing 35, 526\u2013529 (2006).","journal-title":"Age Ageing"},{"key":"212_CR31","first-page":"2649","volume":"14","author":"A Ahmad Hamidi","year":"2018","unstructured":"Ahmad Hamidi, A. et al. Immunization rates of pneumococcal, influenza and tetanus vaccines and knowledge and attitudes of adult patients who receive inpatient treatment at hospital: Point prevalence study. Hum. Vaccin Immunother. 14, 2649\u20132653 (2018).","journal-title":"Hum. Vaccin Immunother."},{"key":"212_CR32","doi-asserted-by":"publisher","first-page":"05004","DOI":"10.7189\/jogh.11.05004","volume":"11","author":"P Zhang","year":"2021","unstructured":"Zhang, P. & Gao, J. Evaluation of China\u2019s public health system response to COVID-19. J. Glob. Health 11, 05004 (2021).","journal-title":"J. Glob. Health"},{"key":"212_CR33","doi-asserted-by":"crossref","unstructured":"Barman, T. K. & Metzger, D. W. Disease Tolerance during Viral-Bacterial Co-Infections. Viruses, 13 (2021).","DOI":"10.3390\/v13122362"},{"key":"212_CR34","doi-asserted-by":"crossref","unstructured":"Lee, K. M. et al. Coinfection With Influenza A Virus and Klebsiella oxytoca: An Underrecognized Impact on Host Resistance and Tolerance to Pulmonary Infections. Front. Immunol. 2377. (2018).","DOI":"10.3389\/fimmu.2018.02377"},{"key":"212_CR35","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.4049\/jimmunol.1300014","volume":"191","author":"HE Ghoneim","year":"2013","unstructured":"Ghoneim, H. E., Thomas, P. G. & McCullers, J. A. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J. Immunol. 191, 1250\u20131259 (2013).","journal-title":"J. Immunol."},{"key":"212_CR36","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.21037\/apm.2020.04.05","volume":"9","author":"Y Yu","year":"2020","unstructured":"Yu, Y. et al. Viral infection related venous thromboembolism: potential mechanism and therapeutic targets. Ann. Palliat. Med. 9, 1257\u20131263 (2020).","journal-title":"Ann. Palliat. Med."},{"key":"212_CR37","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1160\/TH09-04-0222","volume":"102","author":"T Zhu","year":"2009","unstructured":"Zhu, T. et al. Association of influenza vaccination with reduced risk of venous thromboembolism. Thromb. Haemost. 102, 1259\u20131264 (2009).","journal-title":"Thromb. Haemost."},{"key":"212_CR38","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.14336\/AD.2020.0603","volume":"11","author":"A Moskalev","year":"2020","unstructured":"Moskalev, A., Stambler, I. & Caruso, C. Innate and Adaptive Immunity in Aging and Longevity: The Foundation of Resilience. Aging Dis. 11, 1363\u20131373 (2020).","journal-title":"Aging Dis."},{"key":"212_CR39","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1111\/j.1538-7836.2011.04425.x","volume":"9","author":"JI Borissoff","year":"2011","unstructured":"Borissoff, J. I. & ten Cate, H. From neutrophil extracellular traps release to thrombosis: an overshooting host-defense mechanism? J. Thromb. Haemost. 9, 1791\u20131794 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"212_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1538-7836.2007.02519.x","volume":"5","author":"JL Degen","year":"2007","unstructured":"Degen, J. L., Bugge, T. H. & Goguen, J. D. Fibrin and fibrinolysis in infection and host defense. J. Thromb. Haemost. 5, 24\u201331 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"212_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/gerona\/62.1.79","volume":"62","author":"AR Folsom","year":"2007","unstructured":"Folsom, A. R. et al. Frailty and risk of venous thromboembolism in older adults. J. Gerontol. A Biol. Sci. Med Sci. 62, 79\u201382 (2007).","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"212_CR42","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/infdis\/jiaa226","volume":"222","author":"JS Turner","year":"2020","unstructured":"Turner, J. S. et al. Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection. J. Infect. Dis. 222, 1235\u20131244 (2020).","journal-title":"J. Infect. Dis."},{"key":"212_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0047-6374(96)01855-6","volume":"94","author":"IN Mbawuike","year":"1997","unstructured":"Mbawuike, I. N. et al. Cytokines and impaired CD8+ CTL activity among elderly persons and the enhancing effect of IL-12. Mech. Ageing Dev. 94, 25\u201339 (1997).","journal-title":"Mech. Ageing Dev."},{"key":"212_CR44","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s10875-010-9448-8","volume":"30","author":"J Nyugen","year":"2010","unstructured":"Nyugen, J. et al. Impaired functions of peripheral blood monocyte subpopulations in aged humans. J. Clin. Immunol. 30, 806\u2013813 (2010).","journal-title":"J. Clin. Immunol."},{"key":"212_CR45","doi-asserted-by":"crossref","unstructured":"Hill, D. L. et al. Impaired HA-specific T follicular helper cell and antibody responses to influenza vaccination are linked to inflammation in humans. Elife, 10 (2021)","DOI":"10.7554\/eLife.70554"},{"key":"212_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4161\/hv.26661","volume":"10","author":"MS Hayney","year":"2014","unstructured":"Hayney, M. S. et al. Age and psychological influences on immune responses to trivalent inactivated influenza vaccine in the meditation or exercise for preventing acute respiratory infection (MEPARI) trial. Hum. Vaccin Immunother. 10, 83\u201391 (2014).","journal-title":"Hum. Vaccin Immunother."},{"key":"212_CR47","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano, A. D. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285\u20131300 (2018).","journal-title":"Lancet"},{"key":"212_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/emph\/eoy024","volume":"2018","author":"M Humphreys","year":"2018","unstructured":"Humphreys, M. The influenza of 1918: Evolutionary perspectives in a historical context. Evol. Med. Public Health 2018, 219\u2013229 (2018).","journal-title":"Evol. Med. Public Health"},{"key":"212_CR49","unstructured":"Martini, M. et al. The Spanish Influenza Pandemic: a lesson from history 100 years after 1918. J. Prev. Med. Hyg. 60, E64\u2013e67 (2019)."},{"key":"212_CR50","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1097\/CCM.0b013e3181c92eeb","volume":"38","author":"MB Rothberg","year":"2010","unstructured":"Rothberg, M. B. & Haessler, S. D. Complications of seasonal and pandemic influenza. Crit. Care Med. 38, e91\u2013e97 (2010) .","journal-title":"Crit. Care Med."},{"key":"212_CR51","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.amjmed.2007.10.040","volume":"121","author":"MB Rothberg","year":"2008","unstructured":"Rothberg, M. B., Haessler, S. D. & Brown, R. B. Complications of viral influenza. Am. J. Med. 121, 258\u2013264 (2008).","journal-title":"Am. J. Med."},{"key":"212_CR52","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jinf.2010.07.013","volume":"61","author":"C Guervilly","year":"2010","unstructured":"Guervilly, C. et al. Significance of high levels of procalcitonin in patients with influenza A (H1N1) pneumonia. J. Infect. 61, 355\u2013358 (2010).","journal-title":"J. Infect."},{"key":"212_CR53","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s00134-009-1746-3","volume":"36","author":"PR Ingram","year":"2010","unstructured":"Ingram, P. R. et al. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med. 36, 528\u2013532 (2010).","journal-title":"Intensive Care Med."},{"key":"212_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.6061\/clinics\/2012(04)05","volume":"67","author":"MB Paiva","year":"2012","unstructured":"Paiva, M. B. et al. The behavior and diagnostic utility of procalcitonin and five other inflammatory molecules in critically ill patients with respiratory distress and suspected 2009 influenza a H1N1 infection. Clinics 67, 327\u2013334 (2012).","journal-title":"Clinics"},{"key":"212_CR55","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0310057X1103900213","volume":"39","author":"NE Hammond","year":"2011","unstructured":"Hammond, N. E., Corley, A. & Fraser, J. F. The utility of procalcitonin in diagnosis of H1N1 influenza in intensive care patients. Anaesth. Intensive Care 39, 238\u2013241 (2011).","journal-title":"Anaesth. Intensive Care"},{"key":"212_CR56","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/thoraxjnl-2020-214896","volume":"75","author":"S Gautam","year":"2020","unstructured":"Gautam, S. et al. Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia. Thorax 75, 974\u2013981 (2020).","journal-title":"Thorax"},{"key":"212_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00011-018-1188-x","volume":"68","author":"D Vasileva","year":"2019","unstructured":"Vasileva, D. & Badawi, A. C-reactive protein as a biomarker of severe H1N1 influenza. Inflamm. Res 68, 39\u201346 (2019).","journal-title":"Inflamm. Res"},{"key":"212_CR58","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3389\/fimmu.2019.00943","volume":"10","author":"A Pathak","year":"2019","unstructured":"Pathak, A. & Agrawal, A. Evolution of C-Reactive Protein. Front. Immunol. 10, 943 (2019).","journal-title":"Front. Immunol."},{"key":"212_CR59","doi-asserted-by":"publisher","first-page":"463","DOI":"10.14336\/AD.2018.0329","volume":"10","author":"F Cyprien","year":"2019","unstructured":"Cyprien, F. et al. Increased Serum C-reactive Protein and Corpus Callosum Alterations in Older Adults. Aging Dis. 10, 463\u2013469 (2019).","journal-title":"Aging Dis."},{"key":"212_CR60","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.exger.2016.12.001","volume":"87","author":"D Frasca","year":"2017","unstructured":"Frasca, D. et al. Human peripheral late\/exhausted memory B cells express a senescent-associated secretory phenotype and preferentially utilize metabolic signaling pathways. Exp. Gerontol. 87, 113\u2013120 (2017).","journal-title":"Exp. Gerontol."},{"key":"212_CR61","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi, C. & Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A Biol. Sci. Med Sci. 69, S4\u2013S9 (2014).","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"212_CR62","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1086\/319275","volume":"183","author":"AR Falsey","year":"2001","unstructured":"Falsey, A. R. et al. Response of C-reactive protein and serum amyloid A to influenza A infection in older adults. J. Infect. Dis. 183, 995\u2013999 (2001).","journal-title":"J. Infect. Dis."},{"key":"212_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-288","volume":"10","author":"O Zimmerman","year":"2010","unstructured":"Zimmerman, O. et al. C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. BMC Infect. Dis. 10, 288 (2010).","journal-title":"BMC Infect. Dis."},{"key":"212_CR64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijid.2016.01.009","volume":"44","author":"W Wu","year":"2016","unstructured":"Wu, W. et al. A new perspective on C-reactive protein in H7N9 infections. Int J. Infect. Dis. 44, 31\u201336 (2016).","journal-title":"Int J. Infect. Dis."},{"key":"212_CR65","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ebiom.2017.07.010","volume":"22","author":"R Gao","year":"2017","unstructured":"Gao, R. et al. C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases. EBioMedicine 22, 133\u2013142 (2017).","journal-title":"EBioMedicine"},{"key":"212_CR66","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/02813432.2021.2006482","volume":"39","author":"NJ Harbin","year":"2021","unstructured":"Harbin, N. J. et al. Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis. Scand. J. Prim. Health Care 39, 527\u2013532 (2021).","journal-title":"Scand. J. Prim. Health Care"},{"key":"212_CR67","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/19485565.2019.1597623","volume":"65","author":"TW McDade","year":"2020","unstructured":"McDade, T. W. et al. C-reactive protein response to influenza vaccination predicts cardiovascular disease risk in the Philippines. Biodemogr. Soc. Biol. 65, 88\u201396 (2020).","journal-title":"Biodemogr. Soc. Biol."},{"key":"212_CR68","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/jcp.38.3.312","volume":"38","author":"JT Whicher","year":"1985","unstructured":"Whicher, J. T. et al. Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza. J. Clin. Pathol. 38, 312\u2013316 (1985).","journal-title":"J. Clin. Pathol."},{"key":"212_CR69","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.2147\/IJGM.S313895","volume":"14","author":"S Fu","year":"2021","unstructured":"Fu, S. et al. The Value of Combined Serum Amyloid A Protein and Neutrophil-to-Lymphocyte Ratio Testing in the Diagnosis and Treatment of Influenza A in Children. Int J. Gen. Med 14, 3729\u20133735 (2021).","journal-title":"Int J. Gen. Med"},{"key":"212_CR70","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/JLB.4AB0220-116RR","volume":"110","author":"MR White","year":"2021","unstructured":"White, M. R. et al. Effects of serum amyloid protein A on influenza A virus replication and viral interactions with neutrophils. J. Leukoc. Biol. 110, 155\u2013166 (2021).","journal-title":"J. Leukoc. Biol."},{"key":"212_CR71","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1126\/science.1097211","volume":"305","author":"DJ Smith","year":"2004","unstructured":"Smith, D. J. et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371\u2013376 (2004).","journal-title":"Science"},{"key":"212_CR72","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1164\/rccm.201212-2341OC","volume":"188","author":"JR Ortiz","year":"2013","unstructured":"Ortiz, J. R. et al. Population-based incidence estimates of influenza-associated respiratory failure hospitalizations, 2003 to 2009. Am. J. Respir. Crit. Care Med. 188, 710\u2013715 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"212_CR73","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1055\/s-0036-1584801","volume":"37","author":"C Peteranderl","year":"2016","unstructured":"Peteranderl, C., Herold, S. & Schmoldt, C. Human Influenza Virus Infections. Semin Respir. Crit. Care Med. 37, 487\u2013500 (2016).","journal-title":"Semin Respir. Crit. Care Med."},{"key":"212_CR74","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","volume":"12","author":"FS Dawood","year":"2012","unstructured":"Dawood, F. S. et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect. Dis. 12, 687\u2013695 (2012).","journal-title":"Lancet Infect. Dis."},{"key":"212_CR75","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1743-422X-8-140","volume":"8","author":"S Mukherjee","year":"2011","unstructured":"Mukherjee, S. et al. Pandemic (H1N1) 2009 influenza virus induces weaker host immune responses in vitro: a possible mechanism of high transmissibility. Virol. J. 8, 140 (2011).","journal-title":"Virol. J."},{"key":"212_CR76","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2147\/ciia.2006.1.3.253","volume":"1","author":"G Sharma","year":"2006","unstructured":"Sharma, G. & Goodwin, J. Effect of aging on respiratory system physiology and immunology. Clin. Inter. Aging 1, 253\u2013260 (2006).","journal-title":"Clin. Inter. Aging"},{"key":"212_CR77","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19, 383\u2013397 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"212_CR78","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/cid\/ciz281","volume":"70","author":"MJ Memoli","year":"2020","unstructured":"Memoli, M. J. et al. Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and \u201cUniversal\u201d Vaccine Development. Clin. Infect. Dis. 70, 748\u2013753 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"212_CR79","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1477","volume":"12","author":"MD de Jong","year":"2006","unstructured":"de Jong, M. D. et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203\u20131207 (2006).","journal-title":"Nat. Med"},{"key":"212_CR80","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1258\/ebm.2009.009256","volume":"235","author":"WC Lin","year":"2010","unstructured":"Lin, W. C. et al. Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators. Exp. Biol. Med. 235, 57\u201365 (2010).","journal-title":"Exp. Biol. Med."},{"key":"212_CR81","doi-asserted-by":"crossref","unstructured":"Gu, Y. et al. The Mechanism behind Influenza Virus Cytokine Storm. Viruses, 13, (2021).","DOI":"10.3390\/v13071362"},{"key":"212_CR82","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1073\/pnas.1321748111","volume":"111","author":"Z Wang","year":"2014","unstructured":"Wang, Z. et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc. Natl. Acad. Sci. USA 111, 769\u2013774 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"212_CR83","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.vaccine.2012.01.015","volume":"30","author":"JE McElhaney","year":"2012","unstructured":"McElhaney, J. E. et al. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 30, 2060\u20132067 (2012).","journal-title":"Vaccine"},{"key":"212_CR84","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1212\/WNL.57.2.295","volume":"57","author":"H Aiba","year":"2001","unstructured":"Aiba, H. et al. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology 57, 295\u2013299 (2001).","journal-title":"Neurology"},{"key":"212_CR85","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jmv.1045","volume":"64","author":"L Kaiser","year":"2001","unstructured":"Kaiser, L. et al. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J. Med Virol. 64, 262\u2013268 (2001).","journal-title":"J. Med Virol."},{"key":"212_CR86","doi-asserted-by":"publisher","first-page":"e28680","DOI":"10.1371\/journal.pone.0028680","volume":"6","author":"X Yu","year":"2011","unstructured":"Yu, X. et al. Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6. PLoS One 6, e28680 (2011).","journal-title":"PLoS One"},{"key":"212_CR87","doi-asserted-by":"publisher","first-page":"e38214","DOI":"10.1371\/journal.pone.0038214","volume":"7","author":"SG Paquette","year":"2012","unstructured":"Paquette, S. G. et al. Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS One 7, e38214 (2012).","journal-title":"PLoS One"},{"key":"212_CR88","doi-asserted-by":"publisher","first-page":"9533044","DOI":"10.1155\/2021\/9533044","volume":"2021","author":"Y Xie","year":"2021","unstructured":"Xie, Y. et al. Specific Cytokine Profiles Predict the Severity of Influenza A Pneumonia: A Prospectively Multicenter Pilot Study. Biomed. Res Int 2021, 9533044 (2021).","journal-title":"Biomed. Res Int"},{"key":"212_CR89","first-page":"145","volume":"22","author":"JE Harris","year":"2019","unstructured":"Harris, J. E. et al. Frequency of troponin elevations in patients with influenza infection during the 2017-2018 influenza season. Int J. Cardiol. Heart Vasc. 22, 145\u2013147 (2019).","journal-title":"Int J. Cardiol. Heart Vasc."},{"key":"212_CR90","doi-asserted-by":"crossref","unstructured":"Taz\u00f3n-Varela, M. A., et al., High-Sensitivity Troponin T: A Potential Safety Predictive Biomarker for Discharge from the Emergency Department of Patients with Confirmed Influenza. J. Pers. Med., 12 (2022).","DOI":"10.3390\/jpm12040520"},{"key":"212_CR91","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.hrtlng.2019.05.009","volume":"49","author":"A Pizzini","year":"2020","unstructured":"Pizzini, A. et al. Prognostic impact of high sensitive Troponin T in patients with influenza virus infection: A retrospective analysis. Heart Lung 49, 105\u2013109 (2020).","journal-title":"Heart Lung"},{"key":"212_CR92","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.mad.2012.03.005","volume":"133","author":"F Olivieri","year":"2012","unstructured":"Olivieri, F. et al. Aged-related increase of high sensitive Troponin T and its implication in acute myocardial infarction diagnosis of elderly patients. Mech. Ageing Dev. 133, 300\u2013305 (2012).","journal-title":"Mech. Ageing Dev."},{"key":"212_CR93","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bj.2020.06.001","volume":"44","author":"G Lippi","year":"2021","unstructured":"Lippi, G. & Sanchis-Gomar, F. Cardiac troponin elevation in patients with influenza virus infections. Biomed. J. 44, 183\u2013189 (2021).","journal-title":"Biomed. J."},{"key":"212_CR94","first-page":"100682","volume":"32","author":"Y Sharma","year":"2021","unstructured":"Sharma, Y. et al. Prognostic impact of high sensitive troponin in predicting 30-day mortality among patients admitted to hospital with influenza. Int J. Cardiol. Heart Vasc. 32, 100682 (2021).","journal-title":"Int J. Cardiol. Heart Vasc."},{"key":"212_CR95","doi-asserted-by":"publisher","first-page":"oeac051","DOI":"10.1093\/ehjopen\/oeac051","volume":"2","author":"AM Nordenskj\u00f6ld","year":"2022","unstructured":"Nordenskj\u00f6ld, A. M. et al. Prevalence and prognostic implications of myocardial injury in patients with influenza. Eur. Heart J. Open 2, oeac051 (2022).","journal-title":"Eur. Heart J. Open"},{"key":"212_CR96","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s00134-012-2565-5","volume":"38","author":"B Borgatta","year":"2012","unstructured":"Borgatta, B. et al. Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection. Intensive Care Med 38, 1152\u20131161 (2012).","journal-title":"Intensive Care Med"},{"key":"212_CR97","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1515\/cclm-2016-0741","volume":"55","author":"S Zheng","year":"2017","unstructured":"Zheng, S. et al. Elevation of creatine kinase is linked to disease severity and predicts fatal outcomes in H7N9 infection. Clin. Chem. Lab Med 55, e163\u2013e166 (2017).","journal-title":"Clin. Chem. Lab Med"},{"key":"212_CR98","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s10157-020-02006-3","volume":"25","author":"K Ishibuchi","year":"2021","unstructured":"Ishibuchi, K. et al. Elevation of creatine kinase is associated with acute kidney injury in hospitalized patients infected with seasonal influenza virus. Clin. Exp. Nephrol. 25, 394\u2013400 (2021).","journal-title":"Clin. Exp. Nephrol."},{"key":"212_CR99","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1172\/JCI117323","volume":"94","author":"KL Hartshorn","year":"1994","unstructured":"Hartshorn, K. L. et al. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J. Clin. Invest 94, 311\u2013319 (1994).","journal-title":"J. Clin. Invest"},{"key":"212_CR100","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/jmv.22105","volume":"83","author":"A Kongchanagul","year":"2011","unstructured":"Kongchanagul, A. et al. Decreased expression of surfactant protein D mRNA in human lungs in fatal cases of H5N1 avian influenza. J. Med Virol. 83, 1410\u20131417 (2011).","journal-title":"J. Med Virol."},{"key":"212_CR101","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4149\/av_2012_03_253","volume":"56","author":"CH Boonarkart","year":"2012","unstructured":"Boonarkart, C. H. et al. A reduced expression of surfactant protein D in the lungs of fatal influenza H1N1 cases in 2009. Acta Virol. 56, 253\u2013255 (2012).","journal-title":"Acta Virol."},{"key":"212_CR102","doi-asserted-by":"publisher","first-page":"8527","DOI":"10.1021\/bi4010683","volume":"52","author":"BC Goh","year":"2013","unstructured":"Goh, B. C. et al. Molecular mechanisms of inhibition of influenza by surfactant protein D revealed by large-scale molecular dynamics simulation. Biochemistry 52, 8527\u20138538 (2013).","journal-title":"Biochemistry"},{"key":"212_CR103","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00408-014-9669-3","volume":"193","author":"C Delgado","year":"2015","unstructured":"Delgado, C. et al. Serum surfactant protein D (SP-D) is a prognostic marker of poor outcome in patients with A\/H1N1 virus infection. Lung 193, 25\u201330 (2015).","journal-title":"Lung"},{"key":"212_CR104","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/infdis\/jiab113","volume":"224","author":"JA Chore\u00f1o-Parra","year":"2021","unstructured":"Chore\u00f1o-Parra, J. A. et al. Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019. J. Infect. Dis. 224, 21\u201330 (2021).","journal-title":"J. Infect. Dis."},{"key":"212_CR105","doi-asserted-by":"publisher","first-page":"1557.e9","DOI":"10.1016\/j.cmi.2020.02.018","volume":"26","author":"A Lalueza","year":"2020","unstructured":"Lalueza, A. et al. Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection. Clin. Microbiol. Infect. 26, 1557.e9\u20131557.e15 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"212_CR106","first-page":"593","volume":"29","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Iron status is linked to disease severity after avian influenza virus H7N9 infection. Asia Pac. J. Clin. Nutr. 29, 593\u2013602 (2020).","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"212_CR107","doi-asserted-by":"crossref","unstructured":"Valenzuela-M\u00e9ndez, B. et al. Plasma Levels of Mid-Regional Proadrenomedullin Accurately Identify H1N1pdm09 Influenza Virus Patients with Risk of Intensive Care Admission and Mortality in the Emergency Department. J. Pers. Med.12 (2022).","DOI":"10.3390\/jpm12010084"},{"key":"212_CR108","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-4614-0980-9_9","volume":"726","author":"M Luo","year":"2012","unstructured":"Luo, M. Influenza virus entry. Adv. Exp. Med Biol. 726, 201\u2013221 (2012).","journal-title":"Adv. Exp. Med Biol."},{"key":"212_CR109","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1750-2659.2008.00051.x","volume":"2","author":"U Kumlin","year":"2008","unstructured":"Kumlin, U. et al. Sialic acid tissue distribution and influenza virus tropism. Influenza Other Respir. Viruses 2, 147\u2013154 (2008).","journal-title":"Influenza Other Respir. Viruses"},{"key":"212_CR110","doi-asserted-by":"publisher","first-page":"17399","DOI":"10.1074\/jbc.M112.440362","volume":"288","author":"BS Hamilton","year":"2013","unstructured":"Hamilton, B. S. & Whittaker, G. R. Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12. J. Biol. Chem. 288, 17399\u201317407 (2013).","journal-title":"J. Biol. Chem."},{"key":"212_CR111","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1111\/febs.15613","volume":"288","author":"DZL Mok","year":"2021","unstructured":"Mok, D. Z. L. et al. The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection. FEBS J. 288, 5055\u20135070 (2021).","journal-title":"FEBS J."},{"key":"212_CR112","doi-asserted-by":"publisher","first-page":"e1001053","DOI":"10.1371\/journal.pmed.1001053","volume":"8","author":"MD Van Kerkhove","year":"2011","unstructured":"Van Kerkhove, M. D. et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 8, e1001053 (2011).","journal-title":"PLoS Med"},{"key":"212_CR113","doi-asserted-by":"publisher","first-page":"e0120918","DOI":"10.1371\/journal.pone.0120918","volume":"10","author":"AE Costanzo","year":"2015","unstructured":"Costanzo, A. E. et al. Obesity impairs \u03b3\u03b4 T cell homeostasis and antiviral function in humans. PLoS One 10, e0120918 (2015).","journal-title":"PLoS One"},{"key":"212_CR114","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12160-016-9835-3","volume":"51","author":"AA Prather","year":"2017","unstructured":"Prather, A. A. et al. Sleep Habits and Susceptibility to Upper Respiratory Illness: the Moderating Role of Subjective Socioeconomic Status. Ann. Behav. Med. 51, 137\u2013146 (2017).","journal-title":"Ann. Behav. Med."},{"key":"212_CR115","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3389\/fimmu.2019.01071","volume":"10","author":"R Honce","year":"2019","unstructured":"Honce, R. & Schultz-Cherry, S. Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution. Front. Immunol. 10, 1071 (2019).","journal-title":"Front. Immunol."},{"key":"212_CR116","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/23744235.2016.1201721","volume":"48","author":"Y Sun","year":"2016","unstructured":"Sun, Y. et al. Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis. Infect. Dis. 48, 813\u2013822 (2016).","journal-title":"Infect. Dis."},{"key":"212_CR117","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/cid\/ciq152","volume":"52","author":"JK Louie","year":"2011","unstructured":"Louie, J. K. et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin. Infect. Dis. 52, 301\u2013312 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"212_CR118","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s40475-020-00207-0","volume":"7","author":"L Guti\u00e9rrez-Spillari","year":"2020","unstructured":"Guti\u00e9rrez-Spillari, L., Palma, M. G. & Aceituno-Melgar, J. Obesity, Cardiovascular Disease, and Influenza: How Are They Connected. Curr. Trop. Med. Rep. 7, 92\u201397 (2020).","journal-title":"Curr. Trop. Med. Rep."},{"key":"212_CR119","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1111\/ejn.14758","volume":"52","author":"P Picone","year":"2020","unstructured":"Picone, P., Di Carlo, M. & Nuzzo, D. Obesity and Alzheimer\u2019s disease: Molecular bases. Eur. J. Neurosci. 52, 3944\u20133950 (2020).","journal-title":"Eur. J. Neurosci."},{"key":"212_CR120","doi-asserted-by":"publisher","first-page":"73","DOI":"10.31083\/j.jin2102073","volume":"21","author":"T Piekut","year":"2022","unstructured":"Piekut, T. et al. Infectious agents and Alzheimer\u2019s disease. J. Integr. Neurosci. 21, 73 (2022).","journal-title":"J. Integr. Neurosci."},{"key":"212_CR121","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.4103\/jfmpc.jfmpc_856_19","volume":"9","author":"RK Hadakshi","year":"2020","unstructured":"Hadakshi, R. K. et al. Association between socioeconomic status and influenza-like illness: A study from Western part of India. J. Fam. Med Prim. Care 9, 4587\u20134591 (2020).","journal-title":"J. Fam. Med Prim. Care"},{"key":"212_CR122","doi-asserted-by":"publisher","first-page":"e0128580","DOI":"10.1371\/journal.pone.0128580","volume":"10","author":"AL Cohen","year":"2015","unstructured":"Cohen, A. L. et al. Potential Impact of Co-Infections and Co-Morbidities Prevalent in Africa on Influenza Severity and Frequency: A Systematic Review. PLoS One 10, e0128580 (2015).","journal-title":"PLoS One"},{"key":"212_CR123","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1745691620942516","volume":"16","author":"S Cohen","year":"2021","unstructured":"Cohen, S. Psychosocial Vulnerabilities to Upper Respiratory Infectious Illness: Implications for Susceptibility to Coronavirus Disease 2019 (COVID-19). Perspect. Psychol. Sci. 16, 161\u2013174 (2021).","journal-title":"Perspect. Psychol. Sci."},{"key":"212_CR124","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00006842-199903000-00009","volume":"61","author":"S Cohen","year":"1999","unstructured":"Cohen, S., Doyle, W. J. & Skoner, D. P. Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosom. Med. 61, 175\u2013180 (1999).","journal-title":"Psychosom. Med"},{"key":"212_CR125","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/bioinformatics\/btz758","volume":"36","author":"R Liu","year":"2020","unstructured":"Liu, R., Chen, P. & Chen, L. Single-sample landscape entropy reveals the imminent phase transition during disease progression. Bioinformatics 36, 1522\u20131532 (2020).","journal-title":"Bioinformatics"},{"key":"212_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96875-7","volume":"11","author":"G Lavorgna","year":"2021","unstructured":"Lavorgna, G. et al. A virus-free cellular model recapitulates several features of severe COVID-19. Sci. Rep. 11, 17473 (2021).","journal-title":"Sci. Rep."},{"key":"212_CR127","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1590\/s1679-45082011ao1878","volume":"9","author":"PA Duarte","year":"2011","unstructured":"Duarte, P. A. et al. Procalcitonin in patients with influenza A (H1N1) infection and acute respiratory failure. Einstein 9, 52\u201355 (2011).","journal-title":"Einstein"},{"key":"212_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/cc9324","volume":"14","author":"N Hagau","year":"2010","unstructured":"Hagau, N. et al. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit. Care 14, R203 (2010).","journal-title":"Crit. Care"}],"container-title":["npj Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41514-025-00212-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-025-00212-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-025-00212-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:04:57Z","timestamp":1751396697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41514-025-00212-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":128,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1038\/s41514-025-00212-5","relation":{},"ISSN":["2731-6068"],"issn-type":[{"value":"2731-6068","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Author Jing Yang is employed by the company Wuhan Institute of Biological Products Co., Ltd. The remaining authors declared that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}